147 related articles for article (PubMed ID: 38229315)
1. The role of IgG4 in systemic lupus erythematosus: Implications for pathogenesis and therapy.
Liu Y; Wang Y; Hu M; Xu S; Jiang F; Han Y; Liu Z
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23626. PubMed ID: 38229315
[TBL] [Abstract][Full Text] [Related]
2. Nature, functions, and clinical implications of IgG4 autoantibodies in systemic lupus erythematosus and rheumatoid arthritis.
Pan Q; Lan Q; Peng Y; Cai J; Zheng J; Dickerson C; Xiao H; Liu HF
Discov Med; 2017 Mar; 23(126):169-174. PubMed ID: 28472610
[TBL] [Abstract][Full Text] [Related]
3. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
4. Is systemic lupus erythematosus linked to Immunoglobulin G4 Autoantibodies?
Wei SJ; Xiong Q; Yao H; He QM; Yu PL
Hum Immunol; 2024 Jul; 85(4):110826. PubMed ID: 38954949
[TBL] [Abstract][Full Text] [Related]
5. Association between IgG4 Autoantibody and Complement Abnormalities in Systemic Lupus Erythematosus.
Pan Q; Guo L; Wu J; Cai J; Liao H; Lan Q; Peng Y; He Y; Liu HF
Mediators Inflamm; 2016; 2016():2196986. PubMed ID: 27597802
[TBL] [Abstract][Full Text] [Related]
6. T Helper 2-Associated Immunity in the Pathogenesis of Systemic Lupus Erythematosus.
Ko H; Kim CJ; Im SH
Front Immunol; 2022; 13():866549. PubMed ID: 35444658
[TBL] [Abstract][Full Text] [Related]
7. An Overlapping Case of IgG4-Related Disease and Systemic Lupus Erythematosus.
Naramala S; Biswas S; Adapa S; Gayam V; Konala VM; Bose S
J Investig Med High Impact Case Rep; 2019; 7():2324709619862297. PubMed ID: 31319713
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
[TBL] [Abstract][Full Text] [Related]
9. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
[TBL] [Abstract][Full Text] [Related]
10. Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes.
Li QZ; Zhou J; Wandstrat AE; Carr-Johnson F; Branch V; Karp DR; Mohan C; Wakeland EK; Olsen NJ
Clin Exp Immunol; 2007 Jan; 147(1):60-70. PubMed ID: 17177964
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP.
Karlsson J; Wetterö J; Potempa LA; Fernandez-Botran R; O'Neill Y; Wirestam L; Mobarrez F; Sjöwall C
J Autoimmun; 2023 Sep; 139():103073. PubMed ID: 37356347
[TBL] [Abstract][Full Text] [Related]
12. MMP-9/Gelatinase B Degrades Immune Complexes in Systemic Lupus Erythematosus.
Ugarte-Berzal E; Boon L; Martens E; Rybakin V; Blockmans D; Vandooren J; Proost P; Opdenakker G
Front Immunol; 2019; 10():538. PubMed ID: 30967870
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G
Jiang X; Lan L; Zhou Q; Wang H; Wang H; Chen J; Han F
Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35710146
[TBL] [Abstract][Full Text] [Related]
14. An update on autoantibodies in systemic lupus erythematosus.
Gómez-Bañuelos E; Fava A; Andrade F
Curr Opin Rheumatol; 2023 Mar; 35(2):61-67. PubMed ID: 36695053
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
Thanei S; Vanhecke D; Trendelenburg M
Clin Immunol; 2015 Oct; 160(2):180-7. PubMed ID: 26148903
[TBL] [Abstract][Full Text] [Related]
17. Comparison of IgG subclass autoantibodies in patients with systemic lupus erythematosus and subacute cutaneous lupus erythematosus.
Elenitsas R; Abell E; Lee YY; Huang J; Deng JS
J Dermatol Sci; 1990 May; 1(3):207-15. PubMed ID: 2085508
[TBL] [Abstract][Full Text] [Related]
18. An Overlapping Case of IgG4-related Disease and Klinefelter Syndrome with Lupus-like Serological and Neurological Features: A Case Report and Literature Review.
Takanashi S; Hanaoka H; Ota Y; Kaneko Y; Takeuchi T
Intern Med; 2020 Oct; 59(20):2601-2609. PubMed ID: 32581168
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
20. A glance on the role of IL-35 in systemic lupus erythematosus (SLE).
Bahadorian D; Faraj TA; Kheder RK; Najmaldin SK; Haghmorad D; Mollazadeh S; Esmaeili SA
Cytokine; 2024 Apr; 176():156501. PubMed ID: 38290255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
